| Toggle SummaryNovember 6, 2019
|
GenMark Diagnostics Reports Third Quarter 2019 Results
CARLSBAD, Calif. , Nov. 06, 2019 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (Nasdaq: GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced financial results for the quarter ended September 30, 2019 .
|
View HTML
|
| Toggle SummaryOctober 23, 2019
|
GenMark Diagnostics Schedules Third Quarter 2019 Financial Results Conference Call for November 6, 2019
CARLSBAD, Calif. , Oct. 23, 2019 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ: GNMK) today announced that it plans to release its third quarter earnings results after market close on Wednesday, November 6, 2019. Management will hold a conference call to review the company's financial
|
View HTML
|
| Toggle SummaryAugust 5, 2019
|
GenMark Diagnostics Reports Second Quarter 2019 Results
CARLSBAD, Calif. , Aug. 05, 2019 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (Nasdaq: GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced financial results for the quarter ended June 30, 2019 . Highlights Recognized total revenue of $18.4
|
View HTML
|
| Toggle SummaryJuly 25, 2019
|
GenMark Diagnostics to Participate in the Canaccord Genuity Growth Conference
CARLSBAD, Calif. , July 25, 2019 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ:GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced that the company plans to participate in the upcoming Canaccord Genuity Growth Conference in Boston, MA.
|
View HTML
|
| Toggle SummaryJuly 22, 2019
|
GenMark Diagnostics Schedules Second Quarter 2019 Financial Results Conference Call for August 5, 2019
CARLSBAD, Calif. , July 22, 2019 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ: GNMK) today announced that it plans to release its second quarter earnings results after market close on Monday, August 5, 2019. Management will hold a conference call to review the company's financial
|
View HTML
|
| Toggle SummaryMay 23, 2019
|
GenMark Diagnostics to Participate in Upcoming Investor Conferences
CARLSBAD, Calif. , May 23, 2019 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ:GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced that the company plans to participate in three upcoming investor conferences.
|
View HTML
|
| Toggle SummaryMay 1, 2019
|
GenMark Diagnostics to Present at the Bank of America Merrill Lynch Health Care Conference
CARLSBAD, Calif. , May 01, 2019 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ: GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced that the company plans to participate in the Bank of America Merrill Lynch Heath Care Conference in Las
|
View HTML
|
| Toggle SummaryApril 30, 2019
|
GenMark Diagnostics Reports First Quarter 2019 Results
CARLSBAD, Calif. , April 30, 2019 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (Nasdaq: GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced financial results for the quarter ended March 31, 2019 . Highlights Recognized total revenue of $21.5
|
View HTML
|
| Toggle SummaryApril 30, 2019
|
GenMark Diagnostics Expands Commercial Team
CARLSBAD, Calif. , April 30, 2019 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ:GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced that it has expanded its commercial team in North America with the addition of Michael Harkins as Senior
|
View HTML
|
| Toggle SummaryApril 15, 2019
|
GenMark Diagnostics Schedules First Quarter 2019 Financial Results Conference Call for April 30, 2019
CARLSBAD, Calif. , April 15, 2019 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ: GNMK) today announced that it plans to release its first quarter earnings results after market close on Tuesday, April 30, 2019. Management will hold a conference call to review the company's financial
|
View HTML
|
